Atlas Trials

A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects

Clinical trial NCT00635063 · TERMINATED

Trial details

NCT number
NCT00635063
Sponsor
Sosei
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
CancerPain
Start date
2008-02-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.